CustomerInsights.AI Recognized as 2026 BioTech Breakthrough "Analytics Solution Provider of the Year"
CustomerInsights.AI wins the 2026 BioTech Breakthrough Award for Analytics Solution Provider of the Year, recognizing its impact in advancing Commercial Analytics for Life Sciences.
SCOTTSDALE, Ariz., Nov. 11, 2026 /PRNewswire/ -- CustomerInsights.AI (CIAI) today announced it has been named "Analytics Solution Provider of the Year" in the sixth annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout Life Sciences and Biotechnology companies, products and services around the globe.
CIAI has built an AI-powered analytics ecosystem engineered around the regulatory and data-complexity realities unique to Life Sciences.
ciPARTHENON® unifies fragmented sales, claims, prescriber, patient journey, and market access data into a single real-time environment. The unified Commercial Analytics Cloud includes 40+ ready-to-use analytical apps for Sales, Marketing, and Market Access that reuse common data, business logic, analytics, and intelligence. Through this single shared data foundation, every team works from the same numbers.
In addition, ciATHENA® is CIAI's Agentic AI layer delivering action-oriented intelligence to teams. The end-to-end commercial command center for Life Sciences unifies data, intelligence, Agents, and workflows. ciATHENA® connects the Agents, intelligence, data, and workflows already running across an enterprise, whether native, client-built, or third-party. It grounds every Agent in one Commercial Knowledge Base built on decades of Pharma experience, orchestrates how they work together, and holds them to a single governance standard, while understanding the specific decisions each team must make.
Both solutions within the analytics ecosystem supports all relevant commercial functions, including Value & Access, Patient Journey & Treatment Insights, Brand Performance & Growth Analytics, Marketing & Customer Engagement, Commercial Excellence & Sales Operations, and Data Strategy, Management & Governance. CIAI works on an outcomes-based model, backed by leadership and data science teams with deep expertise across Life Sciences commercial analytics and a strong understanding of complex commercial priorities.
"In Life Sciences, innovation is only meaningful when it creates measurable impact. At CIAI, our differentiation extends well beyond technology. Our Pharma-trained AI and Data Science teams combine deep industry expertise with advanced technology to help clients navigate complex data and stakeholder challenges, and turn insights into action at the speed their businesses demand," said Abhay Jajoo, CEO of CIAI.
The Life Sciences and Biotechnology sector is rapidly redefining how diseases are discovered, diagnosed, and treated, transforming one of the world's most critical industries. From genomics and gene editing to AI-powered drug discovery, cell and gene therapies, and advanced bioprocessing, biotechnology is delivering faster breakthroughs, more personalized care, and better outcomes for patients around the world.
The mission of the annual BioTech Breakthrough Awards program is to recognize the innovators transforming the global biotechnology and Life Sciences landscape with breakthrough technology. The program conducts a comprehensive analysis of the companies redefining how therapies are researched, developed, manufactured, and delivered. From AI-driven drug discovery platforms and precision medicine to synthetic biology, bioinformatics, and next-generation diagnostics and biomanufacturing, these innovations are enabling Life Sciences organizations to accelerate research, reduce development costs, bring life-changing treatments to market faster, and shape the future of human health.
"CIAI gives Life Sciences organizations an analytics partner built entirely around their needs. For years, Life Sciences commercial teams have lived with the gap between the volume of data available to pharma and biotech organizations and their ability to convert that data into fast, confident action. In this industry, slow or fragmented data is measured in missed opportunities and delayed patient impact," said Bryan Vaughn, Managing Director, BioTech Breakthrough. "CIAI closes this gap — not with generic business intelligence tools retrofitted for pharma, but by delivering business outcomes across every commercial function. CIAI combines technology, domain expertise, and execution to deliver commercial analytics outcomes out of the box. We're thrilled to acknowledge CIAI with 'Analytics Solution Provider of the Year.'"
About BioTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in Life Science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Immunology, Food Science and BioAgriculture, and more. For more information, visit BioTechBreakthroughAwards.com.
About CustomerInsights.AI (CIAI)
CIAI is a Platform-Led Analytics-as-a-Service company built exclusively for the Life Sciences industry. Founded in 2018 by Pharma and Analytics leaders, the company was built on the belief that AI should become a core operational capability rather than a standalone innovation initiative. CIAI has pioneered an outcomes model that combines technology, deep domain expertise, and execution to deliver Commercial Intelligence as measurable outcomes for Life Sciences organizations.
Its flagship platforms, ciPARTHENON® and ciATHENA®, help Pharmaceutical and Biotech organizations modernize analytics ecosystems, reduce operational complexity, and improve commercial decision-making through AI-powered intelligence.
CIAI serves clients ranging from emerging Biotech companies to some of the world's leading Pharmaceutical organizations through teams across North America and India.
SOURCE CustomerInsights.AI
Share this article